![èŠåºãç»å](https://assets.st-note.com/production/uploads/images/82815389/rectangle_large_type_2_c256bf530d09a4f0088e74ada8925767.png?width=1200)
UnitedHealth Group (UNH) Q2 2022 Earnings Callåèš³
ãŠãã€ããããã«ã¹ã»ã°ã«ãŒãïŒUNHïŒ2022幎第2ååæ決ç®é»è©±äŒè°é²
By Motley Fool Transcribing - 7æ 15, 2022 at 11:30AM
2022幎6ææã®UNHã®æ±ºç®èª¬æäŒã
æèããã«ãæã€ãžã§ã¹ã¿ãŒãã£ããã®ããŽã
IMAGE SOURCE: ã¶ã»ã¢ããªãŒã»ããŒã«
ãŠãã€ããããã«ã¹ã»ã°ã«ãŒã (UNH 5.44%)
2022幎第2ååæ決ç®é»è©±äŒè°
2022幎7æ15æ¥åå8æ45åïŒç±³åœæ±éšæé
å
容
æºåãããåè
質åãšåç
ã³ãŒã«åå è
ãã¬ãã©ãŒãã»ãªããŒã¯
ãªãã¬ãŒã¿ãŒ
ãã¯ããããããŸãããŠãã€ããããã«ã¹ã»ã°ã«ãŒãã®2022幎第2ååæ決ç®é»è©±äŒè°ãžããããããŠãã€ããããã«ã¹ã»ã°ã«ãŒãã®æºåçºèšã«ç¶ããŠã質çå¿çã»ãã·ã§ã³ãè¡ããŸãã念ã®ããããã®é話ã¯é²é³ãããŠããŸãã以äžã¯ãéèŠãªçŽ¹ä»æ å ±ã§ãã
ãã®é»è©±äŒè°ã«ã¯ãç±³åœé£éŠèšŒåžæ³ã«åºã¥ãå°æ¥ã®èŠéãã«é¢ããèšè¿°ãå«ãŸããŠããŸãããããã®èšè¿°ã¯ãå®éã®çµæãéå»ã®çµéšãçŸåšã®æåŸ ãšå€§ããç°ãªãåå ãšãªããããªã¹ã¯ãäžç¢ºå®æ§ã䌎ããŸãããããã®ãªã¹ã¯ãäžç¢ºå®æ§ã®ãã¡ã®ãã〠ãã¯ãåœç€Ÿãç±³åœèšŒåžååŒå§å¡äŒã«æåºããå ±åæž(ææ°ããã³å®æçãªæåºæžé¡ã«å«ãŸãã泚ææžããå«ã)ã«èš èŒãããŠããŸãã
ãã®é»è©±äŒè°ã§ã¯ãé GAAP åã®éé¡ãåç §ããŸããéGAAPããŒã¹ã®éé¡ãšGAAPããŒã¹ã®éé¡ã®èª¿æŽè¡šã¯ãåœç€Ÿã®IRããŒãžïŒwww.unitedhealthgroup.comïŒã®è²¡åã»æ¥çžŸå ±åã»ã¯ã·ã§ã³ã«æ²èŒãããŠããŸãããã®é»è©±äŒè°ã§çºè¡šããæ å ±ã¯ãåœç€Ÿãä»æçºè¡šãã決ç®å ±åæžããã³2022幎7æ15æ¥ä»ã®Form 8-Kã«å«ãŸããŠãããåœç€ŸãŠã§ããµã€ãã®IRããŒãžããã¢ã¯ã»ã¹ããããšãå¯èœã§ããããã§ã¯ããŠãã€ããããã«ã¹ã»ã°ã«ãŒãã®æé«çµå¶è²¬ä»»è ã§ããã¢ã³ããªã¥ãŒã»ãŠã£ããã£ã«äŒè°ãåŒãç¶ããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ã±ã€ã㣠ããããšãããããŸããçããããã¯ããããããŸããæ¬æ¥ã¯ãéãŸãããã ãããããšãããããŸãããŠãã€ããããã«ã¹ã»ã°ã«ãŒãã¯ãããå€ãã®äººã ã«ãããå¹æçã«ãã€ãªããã®ãã質ã®é«ãã±ã¢ãæäŸãããšããç®æšãå®è¡ããæç¶çãªå¢ãã§äžåæãçµããããšãã§ããŸããããã®ããã«ãç§ã¯36äžäººã®ååã«æè¬ããããšæããŸããç§ãã¡ã®ããã·ã§ã³ã«å¯Ÿãã圌ãã®æºãããªãã³ãããã¡ã³ããšãç§ãã¡ããµãŒãã¹ãæäŸãã人ã ã«å¯Ÿãã圌ãã®åªåãšãµããŒããããã®ãã¹ãŠãå¯èœã«ããŠããã®ã§ãã
äŒæ¥ã®è©³çŽ°ãªåæ
ã¢ãã«ããŒããã©ãªãª
åžå Žå¶æ¥æéäžã®ã©ã€ãã¹ããªãŒãã³ã°
ãã®ä»å€æ°
ä»ããå§ãã
ãªãã¿ã ãšãŠãã€ããããã«ã¹ã±ã¢ã®äž¡ç€Ÿã®å¥œèª¿ãªæ¥çžŸãåããŠãåœç€Ÿã¯é幎ã®èª¿æŽåŸ1æ ªåœããå©çã®èŠéãã21.40ãã«ãã21.90ãã«ã®ç¯å²ã«æ¡å€§ããŸããå
æ¬çãªããªã¥ãŒããŒã¹ã®ã±ã¢ã¯åœç€Ÿã®æé·æŠç¥ã®äžå¿ããŒãã§ãããããå€ãã®æ£è
ãããšã±ã¢ãããã€ããŒãåŸæ¥ã®ãã£ãŒãã©ãŒã¹ãµãŒãã¹ããããªã¥ãŒããŒã¹å¿åã«ç§»è¡ã§ããããæ¯æŽããŸããç§ãã¡ã¯ãè€æ°ã®æ
¢æ§çŸæ£ãéãããåå
¥ãæºããããŠããªã瀟äŒçããŒãºãªã©ã瀟äŒçã«æã匱ãç«å Žã«ãã人ã
ã®ããã«ãããè¯ãäžè²«ããã±ã¢ææãããäœãç·è²»çšã§å®çŸããããšãç®æããŸãããªãã¿ã ãã«ã¹ãšãªãã¿ã ã¬ãã¯ã¹ã®èšåºãã©ãããã©ãŒã ã¯ãããŒãã£ã«ãããã¹ãã¢ãã¥ãŒãã蚺çæãåšå®
ãŸã§ãäžé£ã®ã±ã¢ç°å¢ãã«ããŒããŠãããåœç€Ÿã®ã±ã¢ããŒã ã¯ãããŒãœãã©ã€ãºãããã³ãã¯ãããã±ã¢ã«ãã£ãŠæ£è
åºæã®ããŒãºã«å¯Ÿå¿ããããšãå¯èœã«ãªã£ãŠããŸãã
åœç€Ÿã®ã¢ãããŒãã¯ãæ£è ãåŠæ¹ãããã±ã¢ããã°ã©ã ãç¶ç¶ããããšãæ¯æŽããããå€ãã®æéãèªå® ã§å¿«é©ã«éããããšãå¯èœã«ããŠããŸãããã®å æ¬çã§æ¶è²»è éèŠã®ã¢ãããŒãã«å¯Ÿããæ¶è²»è ã®é«ãæºè¶³åºŠã¯ãäŸãã°ãåœç€Ÿã®ãã¥ã¢ã«ã»ã¹ãã·ã£ã«ã»ããŒãºã»ãã©ã³ãæäŸãã150äžäººã®äººã ã®ãããã»ããã¢ãŒã¿ãŒã»ã¹ã³ã¢ã80ã§ããããšããã蚌æãããŠããŸããä»æããŸããå»çä¿éºååå šäœã§æé·ãéããŸããããæåŸ ã«æ²¿ãããããçŸåšãã¡ãã£ã±ã¢ããŒã ã¯ä»ç§ã®æ°èŠç»é²ã«åãããµãŒãã¹ã®æçµèª¿æŽã«åãçµãã§ããããããŸã§åæ§ãé«éœ¢è ã®çæ§ã«ãããªã䟡å€ãšå®å®æ§ãäºæž¬å¯èœæ§ããå±ãããããšã«æ³šåããŠããŸãã
ç§ãã¡ã¯ã幎éãéããæ¶è²»è ãããŒã«ãŒãåžå Žããã®ãã£ãŒãããã¯ãå¹ åºãåéããååã®ç¶ç¶çãªæ¹åã«åªããŠããŸããç§ãã¡ã®ã¢ãããŒãã¯ãã客æ§ãšã®æ·±ãé¢ããããã现ããªãµãŒãã¹ãæé«ã®ã±ã¢ãžã®ã¢ã¯ã»ã¹ãæäŸããããšã«æ ¹ãããŠããŸãããã®ã¢ãããŒãã®å©ç¹ã¯ãé©ãã¹ããã®ã§ããã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã®å©çšè ã¯ããã£ãŒã»ãã©ãŒã»ãµãŒãã¹ã®å©çšè ã«æ¯ã¹ãŠå»çè²»ã®èªå·±è² æ ãçŽ40%å°ãªããåå ¥ãéãããŠããé«éœ¢è ã«ãšã£ãŠã¯ã幎éçŽ2,000ãã«ã®ç¯çŽã«ãªããŸãã
ãŸããåŸæ¥ã®ææãµãŒãã¹ãšæ¯ã¹ãŠãã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã»ãã©ã³ã¯ãã©ã€ããªã»ã±ã¢ã«æ倧30%å€ãã®ãªãœãŒã¹ãå²ããã·ãã¢ã®ããã®äºé²çã¹ã¯ãªãŒãã³ã°ãæ€æ»ãµãŒãã¹ãæ倧50%å€ãè¡ã£ãŠããŸããåœç€Ÿã®ãã©ã³ã«å å ¥ããŠããé«éœ¢è ã®åå¿ã¯äžã ã§ãããã©ã³ã®æºè¶³åºŠã¯éå»5幎éã§450ããŒã·ã¹ãã€ã³ãäžæããæ¥çã®ã»ãŒ2åãšãªã£ãŠããŸããæ¶è²»è ã®æºè¶³åºŠã¯ãåæéã«åœç€Ÿã®ãã©ã³ãéžæããé«éœ¢è ãçŽ340äžäººå¢å ããããšãæããã瀺ããŠããŸãã
äžæ¹ãåœå ã®å»çä¿éºäºæ¥ã§ã¯ãéå» 1 幎éã§ãããžã¿ã«ãã¡ãŒã¹ããå«ãååã®é©æ°ãšæ¡å€§ã«ããã25 äžäººä»¥äžã®ã客ããŸã«ãµãŒãã¹ãæäŸã§ããããã«æé·ããŸãããæãããŒãºã®é«ãå°åã«ãããŠæé ãªäŸ¡æ Œãå®çŸãç¶ããããã«ãæ¬æ¥ãOptum Rxã®æ¯æŽãåããUnitedHealthcareã«ããéèŠãªã€ãã·ã¢ãããçºè¡šããŸãã2023幎以éããŠãã€ãããã»ãã«ã¹ã±ã¢ã®å®å šè¢«ä¿éºè ã®ããã«ãåœç€Ÿã®åªå å»è¬åãªã¹ãã«ããããã€ãã®éèŠãªå»è¬åã«ã€ããŠãèªå·±è² æ éãªããèªå·±è² æ é0ãã«ã«ãªããŸããã€ã³ã¹ãªã³ãé床ã®ã¢ã¬ã«ã®ãŒåå¿ã«å¯Ÿãããšããããªã³ãæ¥æ§åæ¯çºäœã«å¯Ÿããã¢ã«ããããŒã«ãªã©ã®å»è¬åãå«ãŸããŸãã
ããã¯è匱ãªäººã ã®å¥åº·ã«ãšã£ãŠéèŠãªã¹ãããã§ããããã倧èŠæš¡ã§é·æçãªå»è¬åã³ã¹ãã®æå¶ã¯ãã³ã¹ãã®æ ¹æ¬çãªèŠå ã§ããã¡ãŒã«ãŒã«ãã補åå®äŸ¡ã®æå¶ãšåŒãäžãã«äŸåããŠããŸããç§ãã¡ã¯ãåºé ã§ã®å²åŒãªã©ãããŸã§ã®æŽ»åãèžãŸããæ¶è²»è ã®èªå·±è² æ é¡ãäžããããã«ãç§ãã¡ã®èœåãçºæ®ããŠãã§ããéãã®ããšããã£ãŠãããããšæããŸããäžæ©äžãã£ãŠã5ã€ã®æé·åéã®ãããããèŠæž¡ãã°ãå ±éã®ããŒããèŠããŠããŸããOptumãšUnitedHealthcareããµãŒãã¹ãæäŸããæ¶è²»è ãšã®é¢ä¿ã®æ·±åã§ãã
2022幎ãéããŠãããå¹ åºãå±€ã®æ¶è²»è ã«ãããŸã§ä»¥äžã«å¹æçã«ãªãŒããããµãŒãã¹ãæäŸããããã®æ©èœãæ¥éã«æ¡å€§ããæè³ãå éããŠããŸãããããã«ã¯ãæ¶è²»è ãä¿¡é Œã§ããå¥åº·é¢é£æ å ±ãèŠã€ããããããããã®ããžã¿ã«äœéšã®ãããªã匷åããæ¶è²»è çŽè²©ãã©ãããã©ãŒã ã«ãããšã³ã²ãŒãžã¡ã³ãã®æ¡å€§ãå«ãŸããŸããããã§ã¯ããããã®åãçµã¿ã«ã€ããŠã瀟é·å Œæé«å·è¡è²¬ä»»è ã®ããŒã¯ã»ãã¯ããŒã³ã«ã話ã䌺ããããšæããŸããããŒã¯ïŒ
ããŒã¯ã»ãã¯ããã³ïŒDirk McMahonïŒ -- 瀟é·å Œæé«å·è¡è²¬ä»»è
ã¢ã³ããªã¥ãŒãããããšãããããŸããã¢ã³ããªã¥ãŒã®ã³ã¡ã³ããåŒãç¶ããç§ããã¯ãæé·æŠç¥ã«ãããé²æç¶æ³ã«ã€ããŠããå°ã詳ããã説æããããšæããŸãããã®é²æã¯ãããªã¥ãŒããŒã¹ã®ã¢ã¬ã³ãžã¡ã³ããéããŠããå€ãã®äººã ã«ãµãŒãã¹ãæäŸããããè¯ãã±ã¢ãæäŸããããã®åãçµã¿ã«è¡šããŠããŸããä»å¹Žã®ç®æšãé 調ã«é²ãã§ããŸãã
ãã®æ¡å€§ã¯ãèšåºã®å質ãšäžè²«æ§ã«å€§ããªåœ±é¿ãäžããŸãããªããã£ã ã»ã±ã¢ã®å»åž«ãšäŸ¡å€ããŒã¹ã®åã決ããè¡ã£ãŠããMAæ£è ã¯ãã±ã¢ãžã®é¢äžãé«ãããŠã§ã«ãã¹ãã§ãã¯ã®éµå®çã¯ã¡ãã£ã±ã¢ææãµãŒãã¹æ£è ãã5ãã€ã³ãé«ããå ¥é¢çã®çŽ20%äœäžã«å¯äžããŠããŸããããã«ããªããã£ã ã»ã±ã¢ã®ããªã¥ãŒã»ããŒã¹ã»ã¢ã¬ã³ãžã¡ã³ããåããCOPDæ£è ã¯ãã¡ãã£ã±ã¢ãã£ãŒãµãŒãã¹æ£è ãããæè¬ã¢ããã¢ã©ã³ã¹ã80%é«ããåŒåžåšå䜵çãçŽ60%æžå°ããææ¥å€æ¥ãåé¿ããããšã«è²¢ç®ããŸããããã®ãããªèšåºçµæã¯ãåœç€Ÿãé·å¹Žã«ããã£ãŠããªã¥ãŒããŒã¹ã®ã±ã¢ã倧èŠæš¡ã«æäŸããŠããå®çžŸã®ã»ãã®äžéšã§ããããã®ãããªã±ã¢ãžã®ã¢ã¯ã»ã¹ãæ¡å€§ããããã®åãçµã¿ãæ¥ãããèŠå ãšãªã£ãŠããŸãã
ãŸããç§ãã¡ã¯ãå¿çšæè¡ã«ãã£ãŠå»çè²»ãåæžããã¢ã¯ã»ã¹ãæ¹åããããšã«ãçµç¹ãšããŠåŒãç¶ãåãçµãã§ããŸããäŸãã°ãç§ãã¡ã¯ãã«ã¹ã±ã¢ã®ããã¯ããŒã³ã匷åããããã«äœåãã«ãã®æè³ãè¡ã£ãŠããŸããäŸãã°ãäžèŠãªè€éããæžããããã®ãã©ãããã©ãŒã ã®åçåãããã·ãŒã ã¬ã¹ãªé¡§å®¢äœéšãå®çŸããããã®ãšã³ãã»ããŒã»ãšã³ãã®è³æ Œç®¡çãæ¶è²»è ãšå»çæäŸè ã®ããã®äžè²«ããèšåºäœéšãä¿é²ããå ±éãã©ãããã©ãŒã ãªã©ã®åéã§ãããããã®æè³ã¯ãæçµçã«ãšã³ãããŒãšã³ãã®ãµãŒãã¹äœéšã®åäžãå šäœçãªéå¶ã³ã¹ãã®åæžããããŠç§ãã¡ããµãŒãã¹ãæäŸãã人ã ãžã®äŸ¡å€ã®åäžã«ã€ãªãããã®ã§ãã
ããã·ã³ãã«ãªäœéšã¯ããªããã£ã ã®éèãµãŒãã¹ããŒã ãéçºããçµ±åæ¶è²»è ã«ãŒãã«é¢ããåãçµã¿ã®äžå¿ããªããŠããŸããæåã®è©Šéšéçšã§ã¯ãæ¶è²»è ãã倧ããªåé¿ããããŸãããå¥åº·é£åã®è³Œå ¥ãå«ãããã¹ãŠã®ç¹å žãåºãåãå ¥ããããŠãã1æã®ã«ãŒãã«ãŸãšãããšããã·ã³ãã«ãããæ¶è²»è ã®å·®å¥åèŠå ãšãªã£ãŠããŸãããã®æåã®åãçµã¿ã«åºã¥ãã2023幎ã«ã¯ã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã®å人äŒå¡å šå¡ã«ãã®ã«ãŒããå°å ¥ããäºå®ã§ãã
ãšã¯ã¹ããªãšã³ã¹åäžã®ããã®ããäžã€ã®éèŠãªèŠçŽ ã¯ãæ¶è²»è ãã©ã³ã¶ã¯ã·ã§ã³ã®æé©åã§ããäŒå¡ã®çæ§ã¯ããã€ã§ãã©ãã§ãã¿ã€ã ãªãŒãªæ å ±ãåŸãããããšãæãã§ããããŸãããä¿éå 容ã®ç解ããããŒãã£ã«èšªåã®å®äºãŸã§ãç§ãã¡ãæäŸããããžã¿ã«ãµãŒãã¹ã«è¯ãåå¿ã瀺ããŠããããšãå¬ããæããŸããã¡ãã£ã±ã¢ã®äŒå¡ã®çæ§ã¯ããã2ã3幎ã®éã«ããžã¿ã«ãšã³ã²ãŒãžã¡ã³ãã170%ãåäžããŠããŸããæåŸã«ããã¡ãŒãã·ãŒã»ãµãŒãã¹ã§ã¯ãè¬å€åž«äž»å°ã®ãµãŒãã¹ãæšé²ããããšã§ãæ¶è²»è ã®ã±ã¢ã®è³ªãšã¢ã¯ã»ã¹ãåäžãããããšã«éåžžã«éç¹ã眮ããŠããŸãã
ç§ãã¡ã¯ã幎æ«ãŸã§ã«700è¿ãå°åè¬å±ãæã€äºå®ã§ãããåŒãç¶ãèšåºçŸå Žã«ãããå°åè¬å±ã®çµ±åãé²ããŠããŸããããã§ã¯ãããŒãã»ãã¡ã€ãã³ã·ã£ã«ã»ãªãã£ãµãŒã®ãžã§ã³ã»ã¬ãã¯ã¹ã«è©±ãè²ããããšæããŸãã
ãžã§ã³ã»ã¬ãã¯ã¹ -- ãšã°ãŒã¯ãã£ãã»ãã€ã¹ãã¬ãžãã³ãå Œæé«è²¡å責任è
ããããšããããŒã¯ãã¢ã³ããªã¥ãŒãè¿°ã¹ãããã«ãç§ãã¡ã¯å匷ãæé·ã®ã¢ã¡ã³ã¿ã ããã£ãŠä»å¹Žã®äžåæãè¿ããŸãããäžåæã®å£²äžé«ã¯1,600åãã«è¶ ã§ãå幎åææ¯13ïŒ å¢ãšãªããŸããããªãã¿ã ãšãŠãã€ããããã«ã¹ã±ã¢ã®äž¡ç€Ÿã2æ¡ã®æé·ãéãããªã©ãæ¥çžŸã¯ãã©ã³ã¹ããæšç§»ããŠããŸãã
ã¯ããã«ãä»å¹ŽãããŸã§ã«èŠ³å¯ãããã±ã¢ãã¿ãŒã³ã«ã€ããŠç°¡åã«è§ŠããŠãããŸããäž»ã«ãéå»æ°å¹ŽéãCOVIDãšéCOVIDã®ã±ã¢æŽ»åã®éã«åè¡¡ããšããŠããé¢ä¿ããCOVIDã®ã±ã¢ã¬ãã«ãäœäžãããšåŸè ãããã»ã©æ¥éã«å埩ããªãããšãèŠåããããŸãããŸããåºæ¬çãªã±ã¢ãã¿ãŒã³ã«ãåŒãç¶ãã°ãã€ãããããç¹å®ã®åéã§ã¯éå»ã®æ°Žæºãäžåã£ãŠããŸããäŸãã°ãå°å ç§ãææ¥ç§ãªã©ã§ãã
ãŸããé«éœ¢è ãéèŠãªäºé²å»çãåããã¬ãã«ãªã©ãããå®å šã«å埩ããŠããåéããããŸããããæ°é±éãCOVIDé¢é£ã®å ¥é¢æ£è æ°ã¯å¢å ããŠããŸãããå¹³åå ¥é¢æ¥æ°ã¯ä»¥åã®æéãšæ¯èŒããŠçããªã£ãŠããŸããç§ãã¡ã¯ãã€ãã以åã®ææã«å»¶æããããããããªãã±ã¢ã«ãã人ã ã®å¥åº·ãžã®é·æçãªåœ±é¿ã«ã€ããŠæ³šææ·±ã芳å¯ããŠããŸããä»ã®ãšãããæ¥æ§æã®å€åã瀺ããããªãã¿ãŒã³ã¯ãŸã èŠã€ãã£ãŠããŸããã
ãã¡ãããçŸåšã®ç°å¢ãåãããŠãããã®ã«ã€ããŠã¯ãå€ãã®åççãªçè«ããããã©ããèå³æ·±ããã®ã§ããããšã¯ééããããŸãããããããç§ãã¡ãå®éã«è¡ã£ãŠããããšã¯ã次ã®ãããªããšã§ããUnitedHealth Groupã®é·å¹Žã®æ £è¡ãšäžèŽããããã«ãç§ãã¡ã®ç¬¬äžã®æå³ã¯ã人ã ãå¿ èŠãªã±ã¢ãåããããããã«ããããšããããŠãã®ããã»ã¹ã«ãããŠã§ããéãæå©ããããããšã§ããç§ãã¡ã¯ããããŸã§ãšåæ§ãå»çè²»ã®ååãšãããã©ã®ããã«æ¥éã«å€åããããéåžžã«å°éããŠãããããã«å¿ããŠç§ãã¡ã®æäŸãããã®ãäœçœ®ã¥ãç¶ããŠãããŸãã
次ã«ãäºæ¥ã«ã€ããŠèª¬æããŸãããªãã¿ã ã»ãã«ã¹ã®åçã¯ã第2ååæã«40åãã«è¶ ã32%å¢å ããŸãããæ¶è²»è 1人åœããã®åçã¯ãããªã¥ãŒããŒã¹ã®åã決ãã®äžã§ãµãŒãã¹ãæäŸããæ£è ã®æé·ã«çœåŒããã30%å¢å ããŸãããããªã¥ãŒããŒã¹ã®æ¡å€§ããµããŒãããããã«ã±ã¢ããªããªãŒãã©ã¯ãã£ã¹ãžã®æè³ãå éãããã«ãããããããå¶æ¥å©çã¯24%å¢ãšãªããŸããã
ãŸãããªãã¿ã ã®å€æ¥æè¡ã»ã³ã¿ãŒã倧ããè²¢ç®ããŸããããããã®ã»ã³ã¿ãŒã¯ãæ£è ãå€ç§å»ã®åªããäœéšãšé«å質ã®èšåºææãæäŸããªããããããã®æé©ãªç°å¢ã§è¡ãããæè¡ã®ç¯å²ãšè€éããé²æ©ããç¶ããŠããŸããåœã»ã³ã¿ãŒã§è¡ãããé«åºŠãªé¢ç¯ãèæ€ãå¿èè¡ç®¡æè¡ã®æ°ã¯ãããã2幎åã«æ¯ã¹ãŠ3åè¿ãã«å¢å ããŠããŸããå»çåŸäºè ã¯ãããã®ã»ã³ã¿ãŒãæäŸããã¡ãªããããŸããŸãèªèããæ¶è²»è ã¯ã±ã¢ã®è³ªãšçµéšãé«ãè©äŸ¡ããNPSã¯åžžã«90ãè¶ ããŠããŸãããªãã¿ã ã€ã³ãµã€ãã®åçã¯å幎æ¯11%å¢ã
åçããã¯ãã°ã¯236åãã«ã§ãå幎æ¯23åãã«ã®æé·ã§ãããåœç€Ÿã¯åŒãç¶ãæè¡çãªé²æ©ãæšé²ããæ å ±æè¡ãããŒã¿åæã®æäŸãµãŒãã¹ã®æ¡å€§ãå«ãã䟡å€ã®é«ãç¥èããŒã¹ã®ãµãŒãã¹ã«ãããŠäººå·¥ç¥èœãæ©æ¢°åŠç¿ãããæ·±ãé©çšããŠããŸãããªãã¿ã Rxã®åçã¯10%å¢ã®çŽ250åãã«ã§ãäžæ žã®PBMã«ãããç¶ç¶çãªå 調ãªè²©å£²å®çžŸãšå®è¡ããªãã³ã«è¬å±ã±ã¢ãµãŒãã¹ã®æé·ãåæ ããŠããŸãããããã®éèŠãã€æ¡å€§ããã±ã¢ãµãŒãã¹ã¯ãè€éãªæ²»çã®å¹æãå³å¯ã«ç£èŠã»è¿œè·¡ãããã€ã¿ãããªå°éãµãŒãã¹ãªã©ã®åéã§ã人ã ã®å¥åº·ã«è²¢ç®ããåäžãããŠããŸãã
ãŠãã€ãããã»ãã«ã¹ã±ã¢ã®è©±ã«æ»ããŸãã売äžé«ã¯ããã¹ãŠã®äºæ¥ããã®è²¢ç®ã«ããã66åãã«ïŒ12ïŒ ïŒã®å€§å¹ ãªäŒžã³ã瀺ããŸãããé«éœ¢è åããµãŒãã¹ã§ã¯ãä»å¹ŽãåŒãç¶ãã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã§æ倧80äžäººã®è¿œå å å ¥ãèŠèŸŒãã§ããŸãããã®ãã¡ 4 åã® 3 ã¯å人åãããã³å£äœåãã®ã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã§ãæ®ãã¯ãã¥ã¢ã«ã»ã¹ãã·ã£ã«ã»ããŒãºã»ãã©ã³ã«ãªãäºå®ã§ãã
ããã«ãããã¡ãã£ã±ã¢ã»ã¢ããã³ããŒãžã®ã·ã§ã¢ã¯7幎é£ç¶ã§å¢å ããèŠèŸŒã¿ã§ããã¡ãã£ã±ã€ãã¯ã第2ååæã«18äžäººå¢å ããŸãããçŸæç¹ã§ã¯ãå·ã®åå€å®ã«ããã¡ãã£ã±ã€ãå å ¥ãžã®åœ±é¿ã¯ãæ¥å¹Žã«çŸãããšäºæ³ããŠããŸããåœç€Ÿã§ã¯ããã®ç§»è¡æéäžã人ã ãé©åãªä¿éºã«åãç®ãªãã¢ã¯ã»ã¹ã§ãããããåŒãç¶ããªãœãŒã¹ã®æºåãé²ããŠããŸãã
åœååæã¯ãåœå ã³ããŒã·ã£ã«ãã©ã³ã®å å ¥è ãæ°ãã« 8 äžäººå¢å ããŸããããã®ãã¡6äžäººã¯ãå£äœä¿éºãšå人ä¿éºã®äž¡æ¹ã§ãã©ã³ã¹ã®ãšãã䌞ã³ã瀺ããŸããã泚ç®ãã¹ãã¯ãå人åãããã³å®¶æåããã©ã³ã®æé·ã®çŽ90%ããããŒãã£ã«èšªåãžã®äŸ¿å©ã§è²»çšå¯Ÿå¹æã®é«ãã¢ã¯ã»ã¹ãç¹åŸŽãšãããã©ã³ãéžæãã人ãã¡ã«ãããã®ã§ãã£ãããšã§ããè³æ¬äœåã¯åŒãç¶ã匷åºã§ãã
第2ååæã®å¶æ¥ãã£ãã·ã¥ãããŒã¯69åãã«ã§ãçŽå©çã®1.3åã§ãããé幎ã®ãã£ãã·ã¥ãããŒã¯åŒãç¶ãçŽ240åãã«ãèŠèŸŒãã§ããŸããä»å¹Žäžåæã«ã¯ãé åœéãšèªç€Ÿæ ªè²·ãã«ããã80 åãã«è¿ããæ ªäž»ã«éå ããŸããã6 æã«ã¯ãåç· åœ¹äŒã«ãã㊠14%ã®å¢é ã決å®ããããã« 70 åãã«ä»¥äžã®è³æ¬ãæäžããŠãå»çæäŸäœå¶ã®åŒ·åãšæ¶è²»è æŠç¥ã®åŒ·åãå³ããå»çãµãŒãã¹ãæäŸãã人ã ãå»çã·ã¹ãã å šäœã®å©çã®ããã«è»¢åž°ãšäœéšãåäžãããããšã«åªããŸãããåè¿°ã®ãšããããã®æé·èŠéãã«åºã¥ããæ¬æ¥ã調æŽåŸã®å©çèŠéãã1æ ªåœãã21.40ãã«ãã21.90ãã«ã®ç¯å²ã«æ¡å€§ããŸããã
ããã§ã¯ãã¢ã³ããªã¥ãŒã«è©±ãæ»ããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ãžã§ã³ãããããšãããããŸããQ&Aã®åã«ãããã€ãã®éèŠãªãã€ã³ãã匷調ããŠãããŸãããŸããç§ãã¡ã®ããžãã¹å šäœã«åŒ·ãå¢ããããããšã§ããç§ãã¡ããµãŒãã¹ãæäŸãã人ã ã¯ã䟡å€ãšãé©æ£ãªã³ã¹ãã§è³ªã®é«ãã±ã¢ãæ±ãç¶ããŠããããªãã¿ã ãšãŠãã€ããããã«ã¹ã±ã¢ã®ä»²éãã¡ã¯ãæ¥ã ãã®æ°Žæºãé«ããŠããŸãã
ãã®ããšã¯ãåœç€Ÿã®æ¥çžŸãã³ã¢ã»ãã©ãããã©ãŒã ã®å匷ãæé·ãçŠå©åçäºæ¥ã®2æ¡æé·ããªãã¿ã ã€ã³ãµã€ãã®åçããã¯ãã°ã®å¢å ãè¬å±ãµãŒãã¹ã®å匷ãæé·ããªãã¿ã ãã«ã¹å šäœã®æ¡å€§ãªã©ã«è¡šããŠãããšèšããã§ããããç§ãã¡ã¯ããã®å ã«å€§ããªãã£ã³ã¹ããããšèããŠããŸããç§ãã¡ã¯ã1æ ªåœããå©çã®13%ãã16%ã®é·æçãªæé·ç®æšãéæãã人ã ãããå¥åº·ãªç掻ãéããå»çå¶åºŠããã¹ãŠã®äººã«ãšã£ãŠããè¯ãæ©èœããããæ¯æŽãããšããåœç€Ÿã®äœ¿åœãããã«åé²ãããããšãã§ãããšç¢ºä¿¡ããŠããŸããããã§ã¯ã質åããåãããŸãããäžäººæ§1件ãã€ãé¡ãããŸãã
質åãšåç
ãªãã¬ãŒã¿ãŒ
ããããšãããããŸããã[æåã®è³ªåã¯ã¯ã¬ãã£ã»ã¹ã€ã¹ã®A.J.ã©ã€ã¹ããã§ãã
A.J.ã©ã€ã¹ -- ã¯ã¬ãã£ã»ã¹ã€ã¹ -- ã¢ããªã¹ã
ããããšãããããŸããçãããããã«ã¡ã¯ãçŠå©åçäºæ¥ã®è²©å£²ã·ãŒãºã³ãè¿ããã«ããããéçšäž»ã°ã«ãŒããšã®è©±ãåãã«ã€ããŠããå°ãã³ã¡ã³ããããã ããªãããšæããŸãã2ã€ã»ã©æªè§£æ±ºã®è³ªåããããŸãã
å€ãã®ç£æ¥ã§ãåŸæ¥å¡ãç¶æããå¿ èŠæ§ãåŽååžå Žã®å³ããã«ã€ããŠãè¡ã£ããæ¥ããããŠããããã«æããŸããäžæ¹ãæ¯æ°åŸéã«å¯Ÿããæžå¿µã¯ãã©ã®ããã«äŒè©±ã«åæ ãããŠããã®ã§ããããããŸããéŒè¿«ããåŽååžå Žã«ããäžéšã®å»çä¿éºæäŸè ãžã®ãã¬ãã·ã£ãŒã®åé¡ã¯ãæ¥å¹Žã®çµŠä»èŠéãã«ã€ããŠéçšäž»ãšã®è°è«ã«ã©ã®ãããªåœ±é¿ãåãŒããŠããŸããïŒ
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ã質åãããããšãããããŸãããŸããBrian Thompsonã«è©±ãåŒãç¶ããå°ãèããè¿°ã¹ãŠããããŸãããä»æã®å ±åæžã«ãããããã«ãç¹ã«çŠå©åçäºæ¥ã®é²å±ã«ã¯éåžžã«æºè¶³ããŠããŸããããããE&Iããžãã¹ã§ã¯ãã³ããŒã·ã£ã«ã»ããžãã¹ãéåžžã«å¥œèª¿ãªå¹Žã§ããã
éçšäž»ã¯åœç¶ãèªç€Ÿã®ã³ã¹ãç°å¢ã管çããåŸæ¥å¡ãå©çšã§ãã絊ä»éãé©åãªãã®ã§ããããšã確èªããããšã«é¢å¿ãå¯ããŠãããããŒã ã¯ããªããèšããããªå§åãç解ããããã«éåžžã«æžåœã«åããŠãããšæããŸãããã®æ©äŒã«ããŠãã€ãããã»ãã«ã¹ã±ã¢ã®ãããªäŒæ¥ã®åœ¹å²ãããã«éèŠã§ãããã匷調ããŠãããããšæããŸãããåç¥ã®ããã«ãç§ãã¡ã¯ããã€ã³ãã¬ã®é²ãã ç°å¢ã«ããŸãããŠãã€ãããã»ãã«ã¹ã±ã¢ã®åœ¹å²ã¯ãããã«äŸåããŠãããã¹ãŠã®äŒæ¥ã®åŸæ¥å¡ã«ãæé ãªäŸ¡æ Œã®å»çä¿éºãæäŸããããšãæ¯æŽããããšã§ãããéåžžã«éèŠãªã®ã§ãã
ããã§ã¯ããã©ã€ã¢ã³ã«ä»£ãã£ãŠãç¶æ³ãã©ã®ããã«æšç§»ããŠããããããå°ã詳ããã話ãããŸãããã
ãã©ã€ã¢ã³ã»ãã³ããœã³ -- ãŠãã€ãããã»ãã«ã¹ã±ã¢ã®æé«çµå¶è²¬ä»»è
質åããããšããA.J. ãããŠãAndrewã®ãªãŒãã«æè¬ããŸãããããã®äŒè©±ã®ã»ãšãã©ã¯ãã€ãããŒã·ã§ã³ãšã補åèšèšã®åœ¢ã§äŸ¡å€ããŒã¹ã®ãœãªã¥ãŒã·ã§ã³ãæšé²ãç¶ããã«ã¯ã©ããããããããšããããšãå·¡ã£ãŠã®ãã®ã§ããããããããã£ãšäžå¿çãªããŒãã§ãããç§ãã¡ã¯ãããŒãã£ã«ã»ã±ã¢ã«é¢ããæ°ããã¢ã€ãã¢ãæã£ãŠåžå Žã«ç»å ŽããŸããã
補åãã¶ã€ã³ã ãã§ãªããå»çãè¶ ããå¹ åºãã¢ã¯ã»ã¹ãè¡åçæ³ãšã®çµ±åãªã©ãæ¶è²»è ãããã«ãµããŒãããããšããç¹ã§ããªãã¿ã ãšã®ææºã«ã€ããŠãèãã«ãªã£ãããšæããŸããé·ãéãé«ãå 責éé¡ã¯ãã°ãã°æ¹çšåŒã®äžéšã§ãããããã€ã³ãã¯æ¶è²»è ãæ¬åœã«é転åžã«åº§ããããµãŒãã¹åã®ä¿èšŒè²»çšã§ã©ããªä¿éºãéžã¶ããšãã§ããããã«ããããã¯åžå Žã§æ¬åœã«åé¿ãåŒãã§ããŸãããããŠãæãéèŠãªããšã¯ãéçšäž»ã«ãšã£ãŠãåªããå質ã ãã§ãªããããäœãäŸ¡æ Œåž¯ãæäŸããããšã§ãããã®ããã人æãéçšã®ã¬ãã«ã§ã¯ãªãã䟡å€èŠ³ãéèŠèŠãããããã«ãªãããããã®è£œåã®äŸã¯æ¬åœã«åé¿ãåŒãã§ããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
Brianãã©ããããããšãããããŸããããããŠA.J.ããããŸããŸãããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ãŠã©ã«ãã»ãªãµãŒãã®ãžã£ã¹ãã£ã³ã»ã¬ã€ã¯ã«ãé¡ãããŸãã
ãžã£ã¹ãã£ã³ã»ã¬ã€ã¯ -- ãŠã«ãã»ãªãµãŒã -- ã¢ããªã¹ã
ã©ãã ãã¯ããããããŸããã³ã¹ãååã«ã€ããŠè³ªåã§ãã1ã€ã¯ãäºæ¥ã»ã°ã¡ã³ãå¥ã«èŠãŠããã ããã°ãšæããŸãã
ãããã2ã€ç®ã¯ãæ¥å¹ŽãèŠéããšããæå³ã§ã1ã€ã¯COVIDãããçšåºŠæ£åžžã«ãªãããã«äŸ¡æ Œãèšå®ãå§ããŠããŸããïŒãããŸã§åžžã«éåžžãã©ã¹COVIDã§æ¡å ããŠãããšæããŸãããCOVIDã®å€ä»ããå§ããŠããŸããïŒæ¥å¹Žã¯COVIDãéåžžã®äŸ¡æ Œããé«ãèšå®ããã®ã§ããããããŸããç é¢ã®å䟡ã¯ãéåžžãæ°èŠå¥çŽã§ã¯4ïœ5%ã§ãããæ¥å¹Žã¯ã©ã®çšåºŠã«ãªãããã§ãããããããããšãããããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãžã£ã¹ãã£ã³ãã質åããããšãããããŸãããã®åã«ããžã§ã³ã«äºæ¥ã³ã¹ãã®æšç§»ã«ã€ããŠå°ãã³ã¡ã³ãããŠããããããšæããŸãã次ã«ããã©ã€ã¢ã³ãããç é¢ã§ã®äŒè©±ã«ã€ããŠãã©ã®ãããªãã®ãèŠãããããå°ãå±æãè¿°ã¹ãŠããããŸããããã§ãäžæ©åŒããèŠç¹ããã2ã€ã»ã©æèŠãè¿°ã¹ãããŠããã ããŸãã
ãŸããäºæ¥å šäœãèŠæž¡ããšãéåžžã«å€§ããªæé·ã®æ©äŒãšããã®ããã®æè³ã®å€§ããªå¯èœæ§ãèŠããŠããŸããããã¯çµç¹å šäœã®ããã³ã·ã£ã«ã瀺ãéåžžã«ããžãã£ããªå åã ãšæããŸãããããã®ç¹ã«ã€ããŠã¯ããžã§ã³ãããå°ã詳ãã説æããŸãã2023幎ã«ã€ããŠã¯ãäŸ¡æ Œèšå®ã«ã€ããŠããŸã詳ããè¿°ã¹ãã€ããã¯ãããŸããã
ãããããã€ããšåãããã«ãç§ãã¡ã¯ç°å¢ã®ã³ã¹ãã»ãã¬ã³ãã®äžã«ããåºæ¬çãªçŸè±¡ãéåžžã«å°éããŠããŸãããã¡ããããã®äžã«ã¯COVIDãã©ã®ãããªç¶æ³ã«ããã®ãããããã¯ãªãã®ãããšããããšãå«ãŸããŸãããããŠããã³ãããã¯ã®ãããªäžç¢ºå®æ§ãæ·±ãå°éããããšããç§ãã¡ã¯åŠãã§ãããšæããŸãããã®æ°ã«æéãç§ãã¡ã¯ãã®ããšãå°ããã€ç解ããŠããŸããã
ãã¡ãããç°å¢ã«ãããã€ã³ãã¬ã®åŸåãªã©ã«ãæ¬æãæãå¿ èŠããããŸãããããã®ããšããç§ãã¡ããããã®ããšãã©ãèããããšããããšã«ã€ãªãã£ãŠããã®ã§ããã質åã®æåã®éšåã«ã€ããŠããå°ã詳ãããèããããã®ã§ããžã§ã³ã«åããŸãã
ãžã§ã³ã»ã¬ãã¯ã¹ -- ãšã°ãŒã¯ãã£ãã»ãã€ã¹ãã¬ãžãã³ãå ŒããŒãã»ãã¡ã€ãã³ã·ã£ã«ã»ãªãã£ãµãŒ
ãã¯ããããããŸãããžã£ã¹ãã£ã³ãç¹ã«ããã®åœ±é¿åã¯ããªããæ±ããŠãããã®ã§ãããç§ãã¡ã®èããã©ã®ããã«çºå±ããŠããããšããããšã§ããç§ã®ã³ã¡ã³ãã§ã¯ãéå»2幎éãCOVIDã±ã¢ãšéCOVIDã±ã¢ã¯éåžžã«ãã©ã³ã¹ã®åããé¢ä¿ã§ãã£ããšããããšãã話ãããŸããã
ãããããæ°ã«æã§å°ãå€åããŠããŸããCOVIDã±ã¢ã®ã¬ãã«ãäžãã£ãããšã§ã第2ååæã¯ç¬¬1ååæã«æ¯ã¹ãŠå ¥é¢æ£è æ°ããããã3åã®1çšåºŠã«ãªã£ããšæãããŸããããããCOVID以å€ã®å©çšãå¢å ãããããCOVIDã®å©çšãæžå°ããããã§ã¯ãããŸããããã®ããšããããæ°ã«æã§èŠãããéèŠãªæœåšçèŠå ã§ãã
ããã²ãšã€éèŠãªããšã¯ãå»çå šäœãèŠæž¡ããšãCOVIDã«ããå ¥é¢ã®ééãããã³ãããã¯ä»¥éã®ã©ã®æç¹ãããé·ããªã£ãŠããããšã§ãããã®ããšã¯ãCOVID以å€ã®å»çãã¿ãŒã³ãããé®®æã«ãããã®ã§ããã€ãŸãããã®ãããªç¶æ³äžã§äœãèµ·ãã£ãŠããã®ããæããã«ããã®ã«åœ¹ç«ã£ãŠããŸãããã1ã€ãç§ãã¡ãèŠãŠããç¹ã«ã€ããŠã話ããŸããšãããæ£åžžãªã¬ãã«ãžãšåãã£ãŠããå»çãããã€ãèŠãããããã«ãªãããšãŠãå¿åŒ·ãæã£ãŠããŸãã
ããã¯ãå°æ¥ã®ã±ã¢ã®ææšãšãªããããªãéèŠãªãã®ã§ããäŸãã°ãç§ãã¡ã«ãšã£ãŠéåžžã«éèŠãªããšããããŸããã¡ãã£ã±ã¢æ£è ããã®å¥åº·èšºæã®å蚺çã¯ããã³ãããã¯åã®åºæºå€ãŸã§æ»ã£ãŠããŸããããã¯ãæ£è ããã«å¿ èŠãªæ²»çãæäŸããäžã§éåžžã«éèŠãªããšã§ãã
åååŠæ¹ç®ã¯åºæºå€ãå°ãäžåãåŸåã«ãããå¿ èŠãªæ²»çãåããããããã«ãªã£ãŠããŸãããå€§è žå èŠé¡æ€æ»ãªã©ã®äºé²å»çããåºæºå€ãŸã§å埩ããŠããŸãããã®ãããªããšã¯ãå°æ¥ã«ã€ããŠã©ãèããããšããç¹ã§ããã¹ãŠåœ±é¿ããŸããç§ãã¡ã¯ã人ã ãå¿ èŠãªå»çãåããããããã«ããªããã°ãªããŸããã
ç§ãã¡ã¯ãé«éœ¢è å±€ã«æã倧ããªåé¿ãããããšãå®æããŠããŸãããã®çç±ã®ã²ãšã€ã¯ãç§ãã¡ãé«éœ¢è ã®èªå® ã蚪åããã±ã¢ã«åœ±é¿ãäžããããšãã§ããããã§ããCOVIDã«ããå ¥é¢ãå°æ¥çã«ã©ã®ãããªåœ±é¿ãåãŒããã«ã€ããŠã¯ãéåžžã«é«ãè©äŸ¡ããŠããŸããCOVIDã«ããå ¥é¢ã¯ã1æ以éäžæçã«æžå°ããŠããŸããããçŸåšã¯åã³å¢å ããŠããŸãã
ä»å¹Žããæ¥å¹Žã«ãããŠã©ã®ããã«æšç§»ãããããŸããå€åãç¶ãå¯èœæ§ãåã³å éããå¯èœæ§ã«ã€ããŠããéåžžã«æ éãªèŠéãããã£ãŠããŸãããã©ã€ã¢ã³ïŒ
ãã©ã€ã¢ã³ã»ãã³ããœã³ -- ãŠãã€ãããã»ãã«ã¹ã±ã¢ã®æé«çµå¶è²¬ä»»è ã§ãã
ããã§ããããžã§ã³ãããªããããŸããŸãšããŠããããšæããŸããç§ã¯ãã€ã³ãã¬ã«ã€ããŠã ãä»ãå ããããšæããŸãããã¡ãããJustinããããããåãã®ããã«ãç§ãã¡ã¯ã€ã³ãã¬ãå«ãã³ã¹ãèŠéããç«ãŠãŠããŸãã
ãããã€ããŒã»ããŒãããŒãšã®äººä»¶è²»ã«ã€ããŠã¯ã確ãã«ãã®éãã ãšæããŸãããŸããé·æå¥çŽã®å Žåãæéã®çµéãšå¥çŽæŽæ°ã®ä»æ¹ã«ããã2022幎ããã2023幎ã®æ¹ã圱é¿ã倧ããããšã¯ãæ³åããã ãããšæããŸãããã®ãããªãã€ãããã¯ãªç°å¢ã«ã¯ååã«é æ ®ããŠããŸããããããšãããããŸããã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ããããšãããããŸãããžã£ã¹ãã£ã³ãããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ã¢ã«ã¬ã³ã»ã¹ã¿ã³ã¬ãŒã®ãªãããŒã»ãŽãŒã«ãã¯ããµãŒã«ãé¡ãããŸãã
ãªãããŒã»ãŽãŒã«ãã¯ããµãŒ -- ã¢ã«ã¬ã³ã¹ã¿ã³ã¬ãŒ -- ã¢ããªã¹ã
ã¯ããããã«ã¡ã¯ããã¯ããããããŸããç§ã¯Optum Rxã«çŠç¹ãåœãŠãŸãã
Optum Rxã«ã€ããŠã¯ãæããã«ãããã©ã€ã³ãšäŒå¡æ°ã®äŒžã³ã¯éåžžã«å¥œèª¿ã§ãããããŒãžã³ãžã®æ³¢åã¯å¿ ãããèŠãããŸãããã§ã¯ãããã¯ã¹ã®èŠ³ç¹ãããã©ã®ãããªãã¬ã³ããæ¥çžŸã«åœ±é¿ãåãŒããŠããã®ã§ããããããŸããOptum Rxã®ä»åŸã®å±éã«ã€ããŠã©ã®ããã«èããã°ããã§ããããã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãªãã㌠-- ãããçŽ æŽãããããªãããŒã質åãããããšãããããŸããããã¶ãŒã«ã³ã¡ã³ãããé¡ãããåã«ãOptum Rxãåãå·»ãå§åçãªåœå¢èª¿æ»ã®1ã€ã¯ãæ¬åœã«å匷ãæé·ãšãéåžžã«éèŠãªæ°èŠé¡§å®¢ã®ç²åŸã ãšèããŠããŸãããããŠãã¡ããããåç¥ã®ããã«ãããããµããŒãããããã®æºåãšããŠãããã³ãããŒãã£ã³ã°æè³çŸè±¡ãçºçããŸããããããåçã®äŒžã³ãšå©çã®äŒžã³ã®éã«ã©ã°ãããçç±ã®äžã€ã§ãã
ãã¶ãŒããããã®èŸºã®ããšãããå°ã詳ããæããŠããã ããŸããã
Heather Cianfrocco -- OptumRxæé«çµå¶è²¬ä»»è
ãããããããšãããããŸããã¢ã³ããªã¥ãŒãèšã£ãããã«ãä»å¹Žã¯æ¬åœã«å匷ãæé·ã§ãæ°èŠé¡§å®¢ã®å¢å ããOptum RxãUnitedHealthcareã®æžç±ã«çŽæ¥å å ¥ãããäŒå¡ã®å¢å ã®çµæã ãšæãããŸããããã¯ãæ°èŠé¡§å®¢ã®å¢å ãOptum RxãUnitedHealthcareã«çŽæ¥å å ¥ããäŒå¡ã®å¢å ã«ãããã®ã§ããæè³ã«é¢ããŠã¯ãååæã«ã¯ããŒãžã³ã«åœ±é¿ãåãŒããŸããã幎éãéããŠããŸãé·æèšç»ã«ãããŠããæè³ã«å¯Ÿãããªã¿ãŒã³ãèŠèŸŒãããšãã§ããŸãã
1ã€ç®ã¯ãã¢ã³ããªã¥ãŒãã話ãã顧客æè³ã§ãã2ã€ç®ã¯ãæ°èŠäºæ¥ã«ã€ããŠã話ããŸããããžã§ããã«ã€ããŠã¯ããµãŒãã¹ãè¡ãå±ããŠããªãå°åã§ããå€ãã®äººã«ãµãŒãã¹ãæäŸã§ãããããæ°ããæ ç¹ãžã®æ¡åŒµãç¶ããŠãããšã話ãããŸãããããããããã«2ã€ã®æ°èŠäºæ¥ãã玹ä»ããŸããããã¯ãä»å¹ŽåºŠã®æè³ã«ã€ããŠçŽ æŽããã瀺åãäžããŠããããšæããŸãã
1ã€ç®ã¯ãåœç€Ÿã®æ¢å顧客ãšãPBMã®æ¢å顧客ãèŠèŸŒã¿é¡§å®¢ã«å¯Ÿå¿ããããšã§ããæ¶è²»è ãè³Œå ¥ããããäŸ¡æ Œã§ããããšã«å ããé«éš°ããŠããç¹æ®è¬å€ã®ã³ã¹ãã«å¯Ÿå¿ãã補åãéçºããããšã§ããç§ãã¡ããã§ã«å€§ããªäŸ¡å€ãæäŸããŠããããŒã«ãåå°ã«ããããšã§ãããã®2幎åã§10åãã«ä»¥äžã®äŸ¡å€ãæäŸããç§ãã¡ã®å°éããŒã«ã¯ããŸã å®æããŠããŸããã
ããã«å€ãã®ãµãŒãã¹ã補åãæäŸããããã«ãç§ãã¡ã¯ä»ãç·æ¥ã«åãçµãã§ããŸãããããŠããããã®æè³ã¯å¿ ãå ±ãããã§ãããããããŠæåŸã«ã玹ä»ããã®ã¯ãè¬å±ã§ããè¬å±ã¯æ¥æé·ããŠããŸãã
ããã¯ãããã©ã€ã³ã®æé·ãšåçã«åœ±é¿ãåãŒããŠããŸããããããç§ãã¡ã¯äºæ¥ãžã®æè³ã ãã§ãªãã以åã«ãã話ããããšãããããžã¿ã«ãšã¯ã¹ããªãšã³ã¹ãžã®æè³ãè¡ã£ãŠããŸããããããç§ãæãæåŸ ããŠããã®ã¯ããµãŒãã¹ãçµ±åããããšã§ããã€ãŸããè¬å€åž«ã第äžã«èãããšããããšã§ãã
ç§ãã¡ã«ã¯7,000人以äžã®è¬å€åž«ããããè¬ã®æäŸãåæã ãã§ãªããç§ãã¡ã®ã¯ã©ã¹æé«ã®æ©èœãéããŠãå人ã®ããã²ãŒããæè²ãã¬ã€ããè¡ãããã«æ¯æ¥æžåœã«åããŠããŸããã§ããããè¬å€åž«ç¬¬äžããµãŒãã¹ç¬¬äžã®ã¢ãã«ã§è¬å±ãçµ±åããããšã¯ããã®ååæã«ãããæ倧ã®æè³ã®ã²ãšã€ã§ãããä»å¹Žã®æ®ãã®æéãéããŠãã®ææãçŸããã§ãããã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
çŽ æŽããããããããšãããã¶ãŒããããŠãªãããŒã質åãããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯BMO Capital Marketsã®Matt Borschã«ç§»ããŸãã
Matt Borsch -- BMO Capital Markets -- ã¢ããªã¹ã
CMSã®ãªã¹ã¯ã³ãŒãã£ã³ã°ã«é¢ããã«ãŒã«ã«ã€ããŠãé£éŠæé«è£ãé£éŠå°è£ããæ§èšŽé¢ã«ããã£ã蚎èšãåãäžããªãããšã«ãªã£ãã®ã¯ã1ã«æã»ã©åã®ããšã ã£ããšæããŸãããã®æå³åãããå°ãªããšããã®ããã»ã¹ã«ããã次ã®ã¹ãããã«ã€ããŠãäœããåããã«ãªãããšãããã°æããŠãã ããã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ããããã質åããããšãããããŸããç§ãã¡ã¯éåžžãé²è¡äžã®æ³çããã»ã¹ã«ã€ããŠã³ã¡ã³ãããããšã¯ãããŸãããä»åã®ã±ãŒã¹ãããã§ããã§ããããããã«ã€ããŠããŸãå€ãã®æ å ±ãæäŸã§ããç«å Žã«ã¯ãããŸãããã質åã«ã¯æè¬ããŸãã
次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ã¹ãã£ãŒãã³ã¹ã®ã¹ã³ããã»ãã£ãã«ã«ãé¡ãããŸãã
ã¹ã³ããã»ãã£ãã« -- ã¹ãã£ãŒãã³ã¹ç€Ÿ -- ã¢ããªã¹ã
ã©ãããããããšãããããŸãããã¯ããããããŸããLHCGã®è²·åã«é¢ããŠè³ªåããããŸããã€ãæè¿ãCMSã¯2023幎ã®åšå® å»çã«é¢ããææ¡ãçºè¡šããŸããããæ¥å¹Žã¯ããªãæåŸ ã¯ããã®æéåŒãäžããææ¡ããŠããŸããã
ãã®æéåŒãäžããã2023幎ã®LHCGè²·åã®è²¡åç圱é¿ã«å¯Ÿããèãæ¹ã«ã©ã®ãããªåœ±é¿ãäžããããèå³ããããŸãããŸããCMSãæçµçãªæéãçºè¡šããéã«ãæéåŒãäžããå®æœããããšã«ãªã£ãå Žåããã®è³ç£ãå¥ã®æ¹æ³ã§å±éããããšã«ã€ããŠã©ãèãããã«åœ±é¿ãäžãããã©ããæããŠãã ãããããããšãããããŸããã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ã¹ã³ãããã©ãããã質åãããããšãããããŸãããŸããç§ãã¡ã¯ãåšå® ã§ã®è³ªã®é«ãã±ã¢æäŸã匷åããæ§ç¯ããããšããå°æ¥ã®éèŠãªç¹åŸŽã«ãªããšä¿¡ããŠããŸãããããŠããããä»ã®ã±ã¢ãããšãã°å»åž«ã«ãã蚺çãããŒãã£ã«ã±ã¢ãªã©ãšé£æºãããããšãã§ããã°ããªããã£ã ã»ãã«ã¹ç€Ÿã®éçºã®äžå¿çãªçŠç¹ã«ãªããŸãã
ã§ããããLHCãOptumã®çµç¹å šäœã«çµ±åããããšã¯ãç§ãã¡ã«ãšã£ãŠæ¬åœã«éèŠã§ããããã®ååŒã«éåžžã«åãå ¥ããŠããã®ã§ããLHCãOptumã®çµç¹å šäœã«çµã¿å ¥ããããšã¯ãç§ãã¡ã«ãšã£ãŠæ¬åœã«éèŠãªããšã§ããã®ååŒã«ãšãŠãåãå ¥ããŠããŸãããã®ååŒã«ãã£ãŠãæäŸã§ããã±ã¢ã®è³ªãå€§å¹ ã«åäžãããšä¿¡ããŠããŸãããããŠãæ£è ãããžã®äŸ¡å€ãããµãŒãã¹ã®æäŸã«åããŠãæ¬åœã«è²¢ç®ã§ãããšèããŠããŸããåžžã«ããã§ããããã«ãé©åãªã±ã¢ãæšé²ããããã«é©åãªã€ã³ã»ã³ãã£ãã»ã·ã¹ãã ã確ç«ããããšãæ¬åœã«éèŠã ãšæããŸãã
ã§ããããCMSããã®ä»ã®æ©é¢ãåšå® ã±ã¢ã®äŸ¡å€ãèªèãç¶ããåšå® ç°å¢ã«ããã質ã®é«ãã±ã¢ã®éçºãä¿é²ããããã®æ¯æŽãšã·ã°ãã«ãäžããããããšããç§ã¯åŒ·ãé¡ã£ãŠããŸãããããã©ããªããã¯ãããããã§ããæ£çŽãªãšãããç§ãã¡ã¯ãã®ã¢ãžã§ã³ãã«éåžžã«åãå ¥ããŠããŸãããªããªããããè¯ãã±ã¢ãåšå® ã®äººã ã«æäŸããããã®æŠç¥çã«éèŠãªæ¹æ³ã ãšèããŠããããã§ããã¹ã³ãããèŠããŠãããŠã»ããã®ã§ãããèªå® ããåºãããªã人ãããã®ã§ãã
ã€ãŸããããã¯æ¬åœã«......ããã¯åœŒãã«ãšã£ãŠéžæçãªãã®ã§ã¯ãªãã®ã§ãã圌ãã«å¿ èŠãªã®ã¯......ç§ãã¡ã¯ã圌ãã«ãã£ãšæ¯æŽãæäŸããæ¹æ³ãèŠã€ããå¿ èŠããããŸãããåç¥ã®ããã«ãç§ãã¡ã«ã¯åŸèšºã®ãããªåéã§é·ãæŽå²ããããäœçŸäžäººãã®äººã ã«çŽ æŽãããå¥åº·è©äŸ¡ãšäºé²æå°ãæäŸããŠããŸãããã§ããããç§ãã¡ã¯ãã®ããšã«ã€ããŠæ¥œèŠ³çã§ãã
CMSããã®ä»ã®æ©é¢ãããã®åéãžã®æè³ãéããŠæ¯æŽã®ã·ã°ãã«ãéãç¶ããŠãããããšã匷ãæãã§ããŸãããããŠãä»å¹Žã®æ®ãã®æéã«ãããã©ã®ããã«å±éãããããèŠå®ããããšæããŸããã質åãããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯JPã¢ã«ã¬ã³ã®ãªãµã»ã®ã«ã§ãã
ãªãµã»ã®ã« -- J.P.ã¢ã«ã¬ã³ -- ã¢ããªã¹ã
ã©ããããããšãããããŸãããã¯ããããããŸããã¢ã³ããªã¥ãŒãOptum Rxã«ã€ããŠã®ã³ã¡ã³ããšãèªå·±è² æ ãªããèªå·±è² æ ãŒãã«é¢ãã2023幎ã®åãçµã¿ã«æè¬ããŠããŸãã
ããããããªãããã¶ãŒããã2ã€ã®ããšã«ã€ããŠã³ã¡ã³ããããã ããªãã§ããããã1ã€ã¯ã2023幎ã®è²©å£²ææã«ã€ããŠããã1ã€ã¯ãRxã®ããªã¥ãŒã»ããŒã¹ã»ã±ã¢ãžã®ã·ããã«ã€ããŠãããªããšç§ã¯éå»ã«è©±ãããããšããããšæããŸãã2023幎ã«åããŠãããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã«ã€ããŠã話ããã以äžã®æ°ããããã°ã©ã ãããã®ã§ããããïŒ
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ãªãµãã質åããããšãããããŸããUHCã¯ãOptum Rxã®æ¯æŽãåããŠãããã€ãã®éèŠãªå»è¬åã«ã€ããŠèªå·±è² æ é¡ãšèªå·±è² æ é¡ã0ãã«ã«ãããšããããŸã£ããæ£ããããšãè¡ã£ãŠãããšæããŸãããããŠããããã®è¬ã察å¿ããçç¶ã«äžå¹žã«ã眹ã£ãŠããŸã£ã人ã ã®çµæã«ã€ããŠèããªããã°ãªããŸãããå¿ èŠãªãšãã«è¬ãå ¥æã§ããªããã°ãç·æ¥æ²»ç宀ã«éã°ãããããã£ãšã²ã©ãç®ã«éãããšã«ãªããŸãã
ãããªãã°ãå人çã«ã倧ããªåœ±é¿ãåºãŸããããã¡ããã³ã¹ããããããŸããã§ããããããã¯ç§ãã¡ã身ãä¹ãåºããŠããã®åé¡ã«åãçµãã®ã«ãæ¬åœã«é©åãªå Žæã ãšèããŠããŸãããã¶ãŒã®ãšããã§ãªãã¿ã Rxã®è²©å£²ææã«ã€ããŠã話ããåã«ãå°ã話ãæ»ããŸãããªããã£ã ã¯å šç€Ÿçã«èšé²çãªè²©å£²ã·ãŒãºã³ã®çã£åªäžã«ããããšããäŒãããããšæããŸãã
Optumã®äžåæãèŠããšãOptum Rxã¯ãã¡ããã®ããšãä»ã®2ã€ã®äºæ¥ãå«ããŠãèšé²çãªã»ãŒã«ã¹ã®ææã«å ¥ã£ãŠããããšãããããŸããã§ããããç§ãã¡ãæäŸãã補åããµãŒãã¹ãåžå Žã«é©åããŠãããšããæå³ã§ãä»ãæ¬åœã«éèŠãªææãªã®ã§ããç§ãã¡ã®äºæ¥ãžã®æè³å§¿å¢ãäžæ®µãšåŒ·åãããçç±ã®ã²ãšã€ã¯ãç§ãã¡ã®ãµãŒãã¹ãéåžžã«å¥œèª¿ã§ããããã§ããããã§ã¯ãHeatherãOptum Rxã®23幎ã·ãŒãºã³è²©å£²ã«ã€ããŠãå ·äœçã«ã©ã®ãããªããšããèãã§ãã? ãŸãããªãµã説æããããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã®åŽé¢ã«ã€ããŠã觊ããŠã¿ãŠãã ããã
Heather Cianfrocco -- OptumRxæé«çµå¶è²¬ä»»è
ãã¡ããã§ããAndrewãèšã£ãããã«ãOptumå šäœã奜調ãªè²©å£²ã·ãŒãºã³ãè¿ããŠãããOptum Rxãåæ§ã«å¥œèª¿ãç¶æããŠããŸãããããŠãç§ãèããã«ããŸã第äžã«ã22幎ã®ã·ãŒãºã³ãæ¬åœã«å¥œèª¿ã ã£ããšããããšã§ããçŸåšãç§ãã¡ã眮ãããŠããç¶æ³ã«ã€ããŠã2ã€ã®èŠ³ç¹ããèããŠã¿ãŸãã
1ã€ç®ã¯ã顧客ã®ç¶æã§ããä»å¹Žã90ïŒ å°ã®é«æ°Žæºã§æšç§»ããèŠèŸŒã¿ã§ãçŸåšãã»ãšãã©ã®äºçŽãå ¥ã£ãŠããŸããæ°èŠããžãã¹ã«é¢ããŠã¯ãæçµéžèãåçãå«ããå¶æ¥æŽ»åã§ãæšå¹Žã®ãã®ææããåé²ããŠããŸããããã¯ããªã¢ã«ã¿ã€ã ã®ã€ãããŒã·ã§ã³ã®ææã ãšæããŸãã
ç§ãã¡ã¯ä»ãã客æ§ãšäžç·ã«ãªã£ãŠãä»æ¥äžã«ãµãŒãã¹ãæäŸããããã«ãåã³åãçµãã§ããŸããç§ãã¡ã¯åŸ ã£ãŠããããã§ã¯ãããŸãããä»ã®åžå ŽèŠå ãç°å¢ãåŸ ã€ããšãªããã€ãããŒã·ã§ã³ãèµ·ãããã³ã¹ããåæžããŠããã®ã§ãããŸããç§ãã¡ã¯æ¥çã§æãåªãã顧客管çããŒã ãšè¿ éãªé¡§å®¢ç®¡çããŒã ãæã£ãŠããããããç§ãã¡ã«å©çããããããŠãããšæããŸãã
ã§ãããã2023幎ã¯ãŸãéåžžã«å¿ãããªããšæããŸãããã®ããã«ã¯ãããçšåºŠã®æè³ãå¿ èŠã§ããã§ãã2023幎ãã客æ§ã«ãµãŒãã¹ãæäŸããããã«ããšãŠãå¿ãããªãããã§ããããªã¥ãŒããŒã¹ã«é¢ããŠã¯ãç§ã¯2ã€ã®ç¹ã§èããŠããŸãã
ãŸããã客æ§ããã®é¢å¿ãšãã¬ãã·ã£ãŒãé«ãŸã£ãŠããããšããããŠãããªã¥ãŒããŒã¹ã»ã±ã¢ã®èŠçŽ ã«åãçµã¿ããã®äžã«ã¹ãã·ã£ãªãã£ã»ãã¡ãŒãã·ãŒãå«ãè¬åŠãçµã¿èŸŒãããšããåãããã客æ§ãããã掻çºã«ãªã£ãŠããŠããããšã§ããç§ãã¡ãæããã¹ã圹å²ã¯ã第äžã«ã補è¬äŒç€Ÿã®ããŒãããŒãæãæé ãªäŸ¡æ Œã§äŸ¡å€ããèšåºçã«é©åãªå»è¬åãæäŸãããã®ææãæšé²ã§ããããã«ããããšã§ãããããŠããã²ãšã€ã¯ã補åãšæ²»çãããã³ã«ãçµ±åããããŒã«ããªã¢ã«ã¿ã€ã ã§æäŸããããšã§ãã
ç§ãã¡ã¯Optum Healthãç¹ã«Optum Careã®åŠæ¹è ãå»çæäŸè ã®å€ããšéåžžã«å¯æ¥ã«ååããŠãåŠæ¹è ãæ£ããéžæãããã®ã«åœ¹ç«ã€ããããããŒã«ããµãŒãã¹ãè©Šè¡é¯èª€ããŠããŸããç§ãã¡ã®ãã©ã³ããã©ã³ã»ã¹ãã³ãµãŒã¯ããµãŒãã¹ã®äºæž¬å¯èœæ§ãé«ããããšãã§ããç§ãã¡ã¯äŸ¡å€ããŒã¹ã®ã·ããã®éèŠãªäžç¿Œãæ ãããšãã§ããã®ã§ããã§ããããç§ãã¡ã¯åŒãç¶ããã®åéã«æè³ããŠãããŸãããPBMã¯ããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã®æšé²ãšè¬å±ã®çµ±åã«ãããŠããã倧ããªåœ¹å²ãæããããšã«ãªããšæããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãã¶ãŒãã©ããããããšãããããŸãããªãµãããªããããªã¥ãŒããŒã¹ã®éšåã«æ³šç®ããã®ã¯ãæ¬åœã«æ£ãããšæããŸããä»Heatherãèšã£ãããã«ãOptum Rxã®ãããªç¬ç«ãã課é¡ã§ã¯ãªããããªã¥ãŒããŒã¹ã®ã±ã¢ææ¡ãã©ã®ããã«æ§ç¯ããããšããç¹ã§ãããã¯éåžžã«Optumã®èª²é¡ã ãšèšããŸããããã¡ããããªããã£ã ã»ãã«ã¹ãäž»å°ããŠãããã©ã€ããªãŒã±ã¢ãããªã¹ãã£ãã¯ã»ã¢ãããŒãã§ã¯ããããé¡èã«è¡šããŠããŸãã
ä»åŸããè¡åå»çãè «çã®ãããªåéã®éæãå®éšãæè³ãç¶ããŠããããšã«ãªãã§ãããããããã¯ç§ãã¡ã解決ãã¹ãéèŠãªåéã§ããããããå»çç°å¢ã®äžã§ã³ã¹ããšè€éãã®è² æ ãã©ãã«ããããèãããšãããããã®åéããç§ãã¡ãåé²ããªããã°ãªããªãå Žæã§ãããç§ãã¡ã¯åé²ããŠããŸããä»åŸ2ã3幎ã®éã«ããã®åé¡ã«ã€ããŠç§ãã¡ãããã£ãšå€ãã®ããšãèãããšæã£ãŠãã ããã
ãªãµãããããšãããããŸããã次ã®è³ªåã§ãã
ãªãã¬ãŒã¿ãŒ
次ã¯ããããã³ãªãµãŒãã®ãžã§ã·ã¥ã»ã©ã¹ãã³ã§ãã
ãžã§ã·ã¥ã»ã©ã¹ãã³ -- ãããã³ãªãµãŒã -- ã¢ããªã¹ã
ããããšãããããŸã ãã¯ããããããŸããä»åŸæ°å¹Žéã®ã·ãã¢åžå Žã«ã€ããŠãçŸåšæ§ç¯äžã®ãã©ã€ããªãŒã±ã¢ãµãŒãã¹ä»¥å€ã«ãéçºãŸãã¯è²·åãå¿ èŠã ãšæãããæ©èœã¯ãããŸããïŒçŸåšåžå Žã«åºãŠããŠãããã®ã§ãå°æ¥çã«ããã«éèŠã«ãªããšæããããã®ã¯ãããŸããïŒ
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ã¯ãããžã§ã·ã¥ãçŽ æŽããã質åã§ãããæ¬åœã«ããããšãããããŸãããŸããã·ãã¢åãããžãã¹ãåŒãç¶ãéåžžã«å¥œèª¿ã§ãã
ä»å¹ŽåããŠå å ¥ãããæ¹ã80äžäººã«éããããšããŠããŸãããããã¯æ¬åœã«éèŠãªããšã§ããããã¯æ¬åœã«éèŠãªããšã§ãããŒã±ããã·ã§ã¢ã®ç¶ç¶çãªæ¡å€§ã§ãããããŠãããããã¹ãŠã¯ãç§ãã¡ãæäŸããå®å®ãããµãŒãã¹ã®äžã«æãç«ã£ãŠããŸãããããŠãã·ãã¢ã®æ¹ã ã®äœéšãã次ã®ã¹ãããã«ã€ãªããã®ã ãšæããŸãã
ãã®ç¹ã«ã€ããŠã¯ãTim Noelããã話ããããããããŸããã
ãã£ã ã»ããšã« -- ã¡ãã£ã±ã¢ïŒãªã¿ã€ã¢ã¡ã³ã瀟æé«çµå¶è²¬ä»»è
[ããŒã¯ãUã«ãŒãã®è©±ãããŸããããããã¯ç§ãã¡ã®çµŠä»ããã䜿ãããããããã®ã§ãäŒå¡ãç解ãäœéšããããããã«ã·ã³ãã«ã«ãããã®ã§ããããããããã ãã«ãšã©ãŸãããç§ãã¡ã¯ããããããäŒå¡ã®çããŸã®äœéšãããç°¡åã«ããããã®äžè²«ããã€ãããŒã·ã§ã³ãæäŸãç¶ããŸããäŸãã°ãããžã¿ã«ãšã¯ã¹ããªãšã³ã¹ããããããŒãœãã©ã€ãºãããã¡ã³ããŒãšã¯ã¹ããªãšã³ã¹ãªã©ã§ããã·ãã¢å±€ã«å¯Ÿããããäžã€ã®ããŒãã¯ãåšå® ãµãŒãã¹ã®æ¡å€§ã§ãã
ããã¯æ¬åœã«éèŠãªããšã§ãããããŸã§ç§ãã¡ã¯ãé«éœ¢è ã®ã±ã¢ã®äžå¿ã¯å»åž«ã®èšºå¯å®€ã ãšèããŠããŸãããããããé«éœ¢è ã®ç§»åã®åé¡ããé«éœ¢è ã®è匱æ§ãèæ ®ãããšãèªå® ã§ã®ã±ã¢ã¯è³ªã®é«ãã±ã¢ãæäŸããããã«çµ¶å¯Ÿã«å¿ èŠãªããšãªã®ã§ããããã倧ããªããŒãã§ãã
ç§ãšããŠã¯ãä»åŸãé«éœ¢è ã®ããã®åšå® ä»è·ãæšé²ãã絊ä»ãããç°¡åã«ããããããããã·ã³ãã«ã«ãæé ãªäŸ¡æ Œã§å©çšã§ãããããæè¡é©æ°ãç¶ããŠãããããšèããŠããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ãã£ã ãããããšãããããŸãããåé ãTimã®ãã€ã¯ã«å°ãäžå ·åããã£ãããã§ããããã§ã圌ã®ã³ã¡ã³ããèããŠããã ããåŸåã®éšåã確å®ã«èããŠããã ããã°ãšæããŸãããããŠãã·ãã¢ã»ã¡ã³ããŒã®ããã®ã€ãããŒã·ã§ã³ãšãä»åŸæ°å¹Žéã®ãµãŒãã¹ã®æ¹åæ§ã«ã€ããŠã®ç·æ¥æ§ãšæ·±ãèå¯ã¯ãå®ã«å®è³ªçãªãã®ã§ãããç§ãã¡ããã®åéã§éåžžã«ç©æ¥µçã§ããããšãåŒãç¶ããç解ããã ãããšæããŸãã
ãžã§ã·ã¥ãã質åããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ãã³ã¯ã»ãªãã»ã¢ã¡ãªã«ã®ã±ãã³ã»ãã£ãã·ã¥ããã¯ã«ãé¡ãããŸãã
ã±ãã³ã»ãã£ãã·ã¥ãã㯠-- ãã³ã¯ãªãã¢ã¡ãªã«ã»ã¡ãªã«ãªã³ã -- ã¢ããªã¹ã
çŽ æŽããããããããšãããããŸãã第4ååæã®è³æ¬ããžã·ã§ã³ã®äŒžã³ã«ã€ããŠå°ãã話ããã ããŸããïŒãã®ããŒã¹ã§å»åž«ãå¢ããç¶ããèœåã競äºç°å¢ã«ã€ããŠã©ã®ããã«ãèãã§ããïŒãŸãããªããã£ã ã»ãã«ã¹ãšæ¯èŒããå Žåã®ããŒãžã³ããã£ãã¿ã«ããžã·ã§ã³ã®ç¶æ³ã«ã€ããŠãã©ã®ããã«èããã¹ãã§ãããããããããšãããããŸããã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
çŽ æŽããã質åã§ãããã±ãã³ãããŒãžã³æ¡å€§ã®æ©äŒã«ã€ããŠã¯ãããã«ãžã§ã³ã«è©±ããŠãããã€ããã§ãããã®åã«ãOptum Healthã®è²¬ä»»è ã§ããããã«ãŒå士ãããå»åž«ã®æ¡çšã«é¢ããå šäœçãªåãã«ã€ããŠã話ããã ããã§ããããã
ã¯ã€ã¢ããã»ããã«ãŒ -- OptumHealthæé«çµå¶è²¬ä»»è
ããã§ãããã±ãã³ãã質åããããšãããããŸãããã¡ãããç§ãã¡ã¯ããªãã¿ã ãã«ã¹ãšãªãã¿ã ã±ã¢ã®å»åž«ãç¶ç¶çã«æé·ããŠããã®ã確èªããŠããŸããäºåçãªè² æ ãå°ãªããå»åž«ã奜ããªä»äºãã€ãŸãèšåºã±ã¢ã«éäžã§ãããšãããç§ãã¡ãæäŸãã䟡å€ææ¡ã«ãå»åž«ããŸããŸãé åãæããŠããããšãããããŸããã
ããªã¥ãŒããŒã¹ã®ã±ã¢ãã©ãã€ã ãžã®ç§»è¡ã¯ç¹ã«é åçã§ãæè¿Optum Healthã«å ãã£ãAtriusãKelseyãªã©ã®å€§èŠæš¡ã°ã«ãŒãããã¬ãžãã³ããåæ¥ããã°ããã®å»åž«ã«ãã¢ããŒã«ããŠããŸããã§ããããä»å¹Žäžã«å»åž«ãšé«åºŠå°éå»ã1äžäººå¢ãããšããæé·èšç»ã«åãã£ãŠé 調ã«é²ãã§ããŸãããæè³å®¶äŒè°ã§ãã®æ°åãçºè¡šã§ããããšã楜ãã¿ã«ããŠããŸãã
ãžã§ã³ã»ã¬ãã¯ã¹ -- ãšã°ãŒã¯ãã£ãã»ãã€ã¹ãã¬ãžãã³ãå ŒããŒãã»ãã¡ã€ãã³ã·ã£ã«ã»ãªãã£ãµãŒ
ã±ãã³ããžã§ã³ã§ãããªãã¿ã ã»ãã«ã¹ã®æé·ãšãããããæåŸ ãããåçã®äŒžã³ãèæ ®ãããšãåŒãç¶ãããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã®ããã®èœåã®æ¡å€§ããã®æ§ç¯ã«æ倧ã®çŠç¹ã眮ãããŠããŸãããã®ãããªæè³ã¯ããã°ããåããã芧ã«ãªã£ãŠããã®ã§ãããåç¥ã ãšæããŸãããå»åž«ãæ¡çšããããšã«ããåçãžã®åœ±é¿ãããããªãåã«è¡ãããŸãããã€ãã©ã€ã³ã«ã€ããŠã話ããããšã2ã€ã®èãæ¹ããããŸãã
ããã¯ãå°æ¥çã«è¿œå ãããå¯èœæ§ã®ãããã®ã§ããããããä»ããã§çãããšã話ãããŠããã®ã¯ãæ¢åã®èšåºã±ã¢æäŸèœåã®ããŒã¹ãšãå°æ¥ã®äŸ¡å€ããŒã¹ã®æ¡å€§ãšãã芳ç¹ããããã®èœåãæ§ç¯ããªããã°ãªããªãå Žæã«ã€ããŠã§ãããªããã£ã ã»ãã«ã¹ã®ããŒãžã³ã8%ãã10%ã®ç¯å²ã«ãšã©ãŸã£ãŠããã®ã¯ããã®ãããªçç±ããã§ããç§ãã¡ã¯ããã®å 10幎éã¯ãã®ãããªç¶æ³ãç¶ããšèŠãŠããŸãã
æ¢åã®ãã€ãã©ã€ã³ãèŠãã°ãããã掻çšããããšã§ãäœå¹Žã«ãããã£ãŠ2æ¡å°ã®åŒ·ããããã©ã€ã³æé·ãå®çŸããããšãã§ããŸãããããŠãç¹ã«ç§ãã¡ããµãŒãã¹ãæäŸããæ£è ããã«ãããã䟡å€ããããããã䟡å€ã«åºã¥ãèœåãžã®æè³ãç¶ç¶ããããšãéèŠã§ãããã®ããã«ãç§ãã¡ã¯8%ãã10%ã®ããŒãžã³çãéæããããšåªåããŠããŸããããã®ãããªå€§èŠæš¡ãªæè³ãç¶ç¶ããããšæåŸ ããŠããŸãããŸããã±ã¢ããªããªãŒã·ã¹ãã ã®æ§ç¯ã«ã€ããŠã¯ããŸã åæ段éã§ããã3åç®ã§ãããšèããŠããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ãžã§ã³ãããããšãããããŸãããã±ãã³ã質åãããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ãSVB蚌åžã®Whit Mayoæ°ã§ãã
Whit Mayo -- SVBèšŒåž -- ã¢ããªã¹ã
ã©ãããããããšãããããŸããä»æã¯æè³åçãããå°ãé«ããšæã£ãŠããã®ã§ãããOptum Venturesã®è©äŸ¡æãªã©ããã€ãã¹ã«ãªããããªããšã¯ãªãã£ãã®ã§ããããïŒè¿å¹Žè¡ã£ãæè³ã«ã€ããŠãã©ã®ãããªè©äŸ¡ãããŠããã®ãæ°ã«ãªããšããã§ããããããšãããããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ããã§ãããããããšãããããŸãã次ã¯ãžã§ã³ã«ãé¡ãããŸãã
ãžã§ã³ã»ã¬ãã¯ã¹ -- å·è¡å¯ç€Ÿé·å Œæé«è²¡å責任è
ãã¯ããããããŸããWhitããã®ååæã§ã¯ãããŒããã©ãªãªãå°ãæŽçããå°æ¥ãèŠæ®ããŠãä»ã®ãããªç°å¢ã«å¯Ÿå¿ã§ããããã«ããããã«ãæ倱ãèšäžããŸãããã§ããããããªãã泚ç®ããŠããã®ã¯ååæããšã®é²æç¶æ³ã ãšæããŸãããç§ã¯ããã®ååæã«ç§ãã¡ãéžæããå®çŸæ倱ã®äžéšãšåŒãã§ããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãžã§ã³ããããŠã£ãããããããããšãããããŸããã次ã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
次ã¯ã³ãŒãŠã§ã³ã»ã¢ã³ãã»ã«ã³ãããŒã®ã²ãŒãªãŒã»ãã€ã©ãŒããã§ãã
ã²ã€ãªãŒã»ãã€ã©ãŒ -- ã³ãŒãŠã§ã³ã»ã¢ã³ãã»ã«ã³ãã㌠-- ã¢ããªã¹ã
ããã«ã¡ã¯ããã¯ããããããŸããKelsey-SeyboldãšAtriusã®ã³ã¡ã³ãã«ã€ããŠãå°ãè£è¶³ãããŠãã ãããä»æã¯60åãã«åŒ±ãè²·åã«è²»ãããŸããããããã¯éå»5幎éã®å¹Žéè²·åé¡ãšã»ãŒåãã§ãããã®èŠæš¡ãèãããšããããã®çµç¹ããã£ãŒã»ãã©ãŒã»ãµãŒãã¹ãªã®ããã£ãããŒã·ã§ã³ãªã®ããããå°ã詳ããæããŠããã ããªãã§ããããïŒäžæã®ãªããã£ã ã»ãã«ã¹ã®å©ççã«ã©ã®ãããªåœ±é¿ãäžããã§ããããããŸããç°å¢ã«ã€ããŠã§ãããããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã®è©äŸ¡é¡ãä¿®æ£ãããåŸã§ãã埡瀟ãç²åŸã§ããè©äŸ¡é¡ã¯å ¬éäŒæ¥ããã¯ããã«äœãã®ã§ããããããããšããã£ãšèå³ãããããããããªããšãããã®ã§ããããïŒ
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãã®ç¹ã«ã€ããŠã¯ããžã§ã³ã«å°ãã³ã¡ã³ãããŠããããŸãããäºæ¥ãæé·ãããããã«è³æ¬ãå€§å¹ ã«æå ¥ãç¶ããŠããããšããç解ããã ããããã§ãããããæããŸãããåç¥ã®ããã«ãåœç€Ÿã®é·æçãªæé·æŠç¥ã®éèŠãªéšåã¯ããã¡ããææ©çãªãã®ã§ãããçŸåšãããã®ãè£ãããšãã§ããæ°ããããžãã¹ãããŒã ãè¿ãå ¥ããããšã«ãã£ãŠè£å®ããããã®ã§ãããã®ããã«ã¯ãããªã¥ãŒã»ããŒã¹ã»ã±ã¢ã®ç¢ºç«ã»ã©åŒ·åãªãã®ã¯ãããŸãããç§ãã¡ã¯ãã¢ããªã¢ã¹ãšã±ã«ã·ãŒã»ã»ã€ãã«ãã®äž¡ç€Ÿãä¿¡é ŒããŠããŸãã
䞡瀟ã«ã¯çŽ æŽãããããŒã ã人æãçµç¹ããããããèªäœãçã®åæ§ãæŽå²ãäººæ Œãæã£ãŠããã®ã§ãäŒç€Ÿã®å€æ§æ§ãé«ããéåžžã«å€ãã®ã¹ãã«ãèŠç¹ããããããŠããããšèããŠããŸãããåç¥ã®ããã«ããããã®äŒæ¥ã®å€ãã¯ãã§ã«...ã©ã¡ãã®å Žåããããªã¥ãŒããŒã¹ã»ã±ã¢ã«é¢ããéèŠãªèãæ¹ãèªãçºå±ãããŠããŠããããã®é©åæ§ã¯éåžžã«é«ããã®ã§ãããã¡ãããæ°ããçµç¹ãè¿ãå ¥ãããšã圌ããå®å šã«è²¢ç®ãããŸã§ã«ã¯ãéåžžã矜ã䌞ã°ããããªããã»ã¹ãå¿ èŠã§ããããã®å Žåãããã§ããããããããç§ãã¡ã¯ãè³æ¬é åãããã«è³¢æã«èãããã«ã€ããŠãéåžžã«ç©æ¥µçã«åãçµãã§ããããã®èœåã«ã€ããŠéåžžã«æ¥œèŠ³çã§ããç¶ããŠããŸãã
ããããããªã¥ãšãŒã·ã§ã³ã®èŠ³ç¹ããã¯ãããå°ãèžã¿èŸŒãã 話ãããŸããããããžã§ã³ïŒ
ãžã§ã³ã»ã¬ãã¯ã¹ -- ãšã°ãŒã¯ãã£ãã»ãã€ã¹ãã¬ãžãã³ãå ŒããŒãã»ãã¡ã€ãã³ã·ã£ã«ã»ãªãã£ãµãŒ
ããã§ãããããªã¥ãšãŒã·ã§ã³ã®èŠ³ç¹ã«é¢é£ããããšã§ãããåœç€Ÿã®ãã€ãã©ã€ã³ãšã±ã¢ããªããªãŒã®æ¡å€§ã«é¢ãã話ã¯ãæ°å¹Žã«ããã話ã§ããä»ã®ä»è·äºæ¥è ãšææºã§ããããã«ãªããŸã§ã«ããããã5幎éã¯ãã®äºæ¥è ãšè©±ãåããç¶ããŠããããšã§ããããéåžžã«é·ããã€ãã©ã€ã³ãéçºããã»ã¹ãé¢ä¿ãçµç¹ãžã®ç解ã
ã€ãŸããç§ãã¡ã¯çžæã®çµç¹ãç解ããçžæã¯ç§ãã¡ãç解ããŠããã®ã§ãããããã¯ããªãé·ãæéã«ããã£ãŠè¡ãããŸãããã®ãããªèŠ³ç¹ããããã®äºæ¥ã®è©äŸ¡ããäœå¹Žãåã«ãã®äºæ¥ã«åå ¥ããŠãããä»é ã¯ã©ããªã£ãŠããã ããããšããããšãèãããšãããããçãããæåŸ ãããããå°ãå€åãå°ãªãã®ã§ã¯ãªãããšæããŸãããŸããå ¬éåžå ŽãèŠéã«å ¥ããŠããããã»ã©æ©ãã¯çŸããŸããã
ãããããã®äžæ¹ã§ãããã»ã©æ©ãé¡åšåããããšããããŸããã§ãããããããç§ãã¡ãéèŠèŠããŠããã®ã¯ããããã®åãçµã¿ãæ°å¹Žã«ããã察話ãšé¢ä¿æ§ç¯ã§ãããéåžž6ã«æã§çµãããã®ã§ã¯ãªããšããããšã§ãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ãã®éãã§ããã²ã€ãªãŒãã質åãããããšãããããŸãããæåŸã«ãã1ã€ã ã質åããããŠãã ãããããã§ã¯æåŸã®è³ªåããé¡ãããŸãã
ãªãã¬ãŒã¿ãŒ
ããããšãããããŸãããŽãŒã«ããã³ã»ãµãã¯ã¹ã®ãã€ãµã³ã»ãªããã«ä»£ãããŸãã
ãã€ãµã³ã»ãªãã -- ãŽãŒã«ããã³ã»ãµãã¯ã¹ -- ã¢ããªã¹ã
çŽ æŽããã ãã¯ããããããŸããæ¶è²»è ãçŽé¢ããŠããçŸåšã®ã€ã³ãã¬ç°å¢äžã§ã®å©çšã«ã€ããŠãèããããã®ã§ãããä»æ¥ã®åžå Žã§ãã«ã¹ã±ã¢ã®æ¶è²»è åãé²ãã§ãããšããããæ¶è²»è ãçŽé¢ããŠããããã€ãã®å§åã«å¯ŸããŠãå»çå¶åºŠã®å©çšæ¹æ³ãã©ã®ããã«å€ããå¯èœæ§ããããšãèãã§ããïŒãŸãããããŸã§ã®ãšãããè¡åã«å€åã®å ãã¯èŠãããŸããïŒ
ã¢ã³ããªã¥ãŒã»ãŠã£ãã㣠-- æé«çµå¶è²¬ä»»è
ãã€ããã質åããããšãããããŸãããã©ã€ã¢ã³ãèŠãŠãããã®ããããŠåœŒã®äŒå¡ã«åæ ãããŠãããã®ãå°ã玹ä»ããããšæããŸããããããç§ãã¡ã¯çãã€ã³ãã¬å§åãç®ã®åœããã«ããŠããŸãããããããæ¶è²»ãšæè³ã®åªå é äœãã©ãããããšããããšã«äººã ã®å¿ãéäžãããŠããããšãç¥ã£ãŠããŸãããã®ããšãç§ãã¡ã«æå³ããã®ã¯ã圌ãã«ãšã£ãŠçŽ æŽãããååŒãããããã«ãç§ãã¡ã¯ããã«åªåããªããã°ãªããªãããšããããšã§ãã
ç§ãã¡ã¯ãæãæé ãªã³ã¹ãã§ãæã質ã®é«ãå»çãæäŸããããã«ãç§ãã¡ã®èœåã掻çšããªããã°ãªããŸããããããPBMã§ãããä»ã®å»çç°å¢ãšã®äº€æžã§ããããŠãã€ããããã«ã¹ã±ã¢ãè¡ãããšã§ããããã¯ãç§ãã¡ãæ ã£ãŠããæ¬åœã«éèŠãªåœ¹å²ã§ãããããããã倧ãã«åã泚ãã§ããã€ããã§ãã次ã«ãæ¶è²»è äœéšã®äžã§ããããã®ãä»ã®ãã®ããããã«åé¡ã§ããããç解ããããšã«é¢ããŠãæ¬åœã«éæã§ããããšãç©èªã£ãŠããŸãã
ä»æ¥çºè¡šããã®ã¯ãæ¬åœã«åŒ±ãç«å Žã®äººãã¡ã®èªå·±è² æ ããªãããšãããã®ã§ããä»ããã®ã¿ã€ãã³ã°ã§ãããèŠåŽããŠãã人ãã¡ãå©ããããã«ããã®ãããªäººãã¡ã«ã¯åŠæ¹ç®ããã¡ããšèšå ¥ããŠãããå¿ èŠãããããšã¯åãã£ãŠããŸãããããã€ã³ãã¬ãåå ã§åŠæ¹ç®ã®èšå ¥ãæ»ããããªããšãããã°ãææªã®äºæ ã«ãªããŸãããã®ãããªäºæ ã¯é¿ãããã
ã§ããããç§ãã¡ã¯ãã®ãããªäºæ ã«é¥ããªãããã«ããŸããããžã¿ã«ã»ãšã³ã²ãŒãžã¡ã³ãã«ã€ããŠèãããšããããŒãã£ã«ã®ãããªãã®ãåŒã³ãããããšæããŸããéžæè¢ãå¢ãããã€ãŸããæ¶è²»è ã«ãã£ãšå€ãã®éžæè¢ãäžãããšããããšã§ãã
ãã®ãããªç°å¢ã§ã¯ããã¬ãã·ã£ãŒã倧ãããã°å€§ããã»ã©ãããã«èº«ãä»»ããªããã°ãªããŸãããã ãããããç§ãã¡ã¯ãã®2幎éãçµç¹ãšããŠãæ¶è²»è æŠç¥ãžã®ã³ãããã¡ã³ããå šé¢çã«åå ãããŠããŸãããä»åŸãåœç€Ÿã®äžæ žãšãªãèœåã¯ãæ¶è²»è 察å¿èœåã§ãããããŠãæ¶è²»è ããã«ã¹ã±ã¢ã«ãããèãæ¹ã®äžå¿ã«æ®ãããšããç¹ã§ãç§ãã¡ãåŒãç¶ã話ãåããæè³ããæ§ç¯ããé©æ°ãããªãŒãããŠããåéã§ãããšæåŸ ããŠããŸãã
æåŸã«ãªããŸããããã©ã€ã¢ã³ã埡瀟ã®éåžžã«å€§ããªã¡ã³ããŒã·ããããèŠããŠãããã®ã«ã€ããŠãããªãã®èŠè§£ããèãããã ããã
ãã©ã€ã¢ã³ã»ãã³ããœã³ -- ãŠãã€ãããã»ãã«ã¹ã±ã¢ã®æé«çµå¶è²¬ä»»è
ã¢ã³ããªã¥ãŒãããããšãããããŸãããã¯ãç°å¢ã«ã€ããŠã¯ãã¢ã³ããªã¥ãŒãç確ã«ææããŠãããšæããŸããããã¯ãããŒãã£ã«ã±ã¢ãšææ¥å€æ¥ã®å©çšãããããã®ã§ãã
æããã«ãããŒãã£ã«ã»ã±ã¢ã¯å¢å ããææ¥å€æ¥ã®å©çšã¯æžå°ããŠããŸãããã€ã³ãã¯ãã®æããäŸã§ãæ¶è²»è ãé転åžã«åº§ããããµãŒãã¹æäŸå Žæãéžæãããã³ã¹ããšè³ªã®äž¡æ¹ãæé©åããããšãã§ããã°ãæ¶è²»è ã¯ããããŸãããããŠããããé«æ§èœã®ãããã¯ãŒã¯ãšçµã¿åãããã°ãåœç¶ãå䟡ãšæ¶è²»è ã®éžæã®äž¡æ¹ã«ãããŠã¡ãªãããåŸãããŸãããã®ãããªç°å¢ã§ã¯ããã®ãããªäŸãæãå€ãèŠããããšæããŸãã
ã¢ã³ããªã¥ãŒã»ãŠã£ã㣠-- æé«çµå¶è²¬ä»»è
ã©ããããããšãããããŸããããããŠãã€ããã質åããããšãããããŸãããæ¬æ¥ã¯ãæéãããã ããããããšãããããŸãããç§ãã¡ã®æŠç¥ãäºæ¥å šäœã«å¢ããäžãç¶ããç§ãã¡ãå¥ä»ããç¹æš©ãæã€ãã¹ãŠã®äººã ãã³ãã¥ããã£ã®ããã«äœ¿åœãåé²ããããã®ã§ãããããçãããèãããã®ãæé·ãšéäžçå®è¡ã®ç©èªã§ããããšãé¡ã£ãŠããŸãã
ä»æã¯ãæž èŽããããšãããããŸãããã質åãããããšãããããŸããããŸãããªãã©ã€ã³ã§ã®ã質åããåŸ ã¡ããŠãããŸããããããšãããããŸãããããã§ã¯ããäžæ¥ãã
ãªãã¬ãŒã¿ãŒ
[ãªãã¬ãŒã¿ãŒã®ãµã€ã³ãªã]
æèŠæéã§ãã0å
é話åå è
ã¢ã³ããªã¥ãŒã»ãŠã£ãã£ïŒAndrew WittyïŒïŒæé«çµå¶è²¬ä»»è
Dirk McMahon -- 瀟é·å ŒCOOïŒæé«å·è¡è²¬ä»»è
John Rex -- ãšã°ãŒã¯ãã£ãã»ãã€ã¹ãã¬ãžãã³ãå Œæé«è²¡å責任è
A.J.ã©ã€ã¹ -- ã¯ã¬ãã£ã»ã¹ã€ã¹èšŒåž -- ã¢ããªã¹ã
ãã©ã€ã¢ã³ã»ãã³ããœã³ -- UnitedHealthcareæé«çµå¶è²¬ä»»è
ãžã£ã¹ãã£ã³ã»ã¬ã€ã¯ -- ãŠã«ãã»ãªãµãŒã -- ã¢ããªã¹ã
Ricky Goldwasser -- ã¢ã«ã¬ã³ã¹ã¿ã³ã¬ãŒ -- ã¢ããªã¹ã
ãã¶ãŒã»ã·ã¢ã³ãããã³ -- OptumRxãæé«çµå¶è²¬ä»»è
ãããã»ãã«ã·ã¥ -- BMOãã£ãã¿ã«ããŒã±ãã -- ã¢ããªã¹ã
ã¹ã³ããã»ãã£ãã« -- ã¹ãã£ãŒãã³ã¹ç€Ÿ -- ã¢ããªã¹ã
ãªãµã»ã®ã« -- J.P.ã¢ã«ã¬ã³ -- ã¢ããªã¹ã
Josh Raskin -- ãããã³ãªãµãŒã -- ã¢ããªã¹ã
ãã£ã ã»ããšã« -- ã¡ãã£ã±ã¢ïŒãªã¿ã€ã¢ã¡ã³ãéšéæé«çµå¶è²¬ä»»è
Kevin Fischbeck -- ãã³ã¯ãªãã¢ã¡ãªã«ã»ã¡ãªã«ãªã³ã -- ã¢ããªã¹ã
ã¯ã€ã¢ããã»ããã«ãŒ -- OptumHealthãæé«çµå¶è²¬ä»»è
Whit Mayo -- SVB Securities -- ã¢ããªã¹ã
Gary Taylor -- ã³ãŒãŠã§ã³ã¢ã³ãã«ã³ãã㌠-- ã¢ããªã¹ã
Nathan Rich -- Goldman Sachs -- ã¢ããªã¹ã
ãã®èšäºãæ°ã«å ¥ã£ãããµããŒããããŠã¿ãŸãããïŒ